Bryan Johnson launches 'Immortals' — a $1M/year all-in health protocol built on his Blueprint data

Summary

Bryan Johnson announced Immortals, a $1M-per-year concierge health program that bundles his personal longevity protocol into a turnkey service. The package includes doctors, comprehensive testing, AI-driven inference, and personalized optimization. He's starting with three clients and positioning it as the premium tier of Blueprint, his evidence-based health company.

The core pitch rests on automation. Johnson has collected a few billion data points on himself over five years, roughly a few hundred million of which are usable. He built an AI system to find relationships in that data and create what he calls a "Brian AI" that watches clients 24/7. Once enrolled, participants undergo comprehensive baseline testing, then follow targeted protocols to isolate and improve specific health markers guided entirely by the AI system. Clients don't choose their regimen; the system tells them what to do. Johnson frames this as autonomous health, analogous to self-driving cars.

The product requires an intake interview to ensure candidates are willing to do the work. Some therapies are uncomfortable, and the protocol demands discipline. Clients can be anywhere in the world.

Johnson describes a deliberate hybrid stack: manual sourcing and third-party testing for physical goods like his Snake Oil olive oil brand, sourced from farmers globally and tested molecule-by-molecule, paired with leading-edge AI for data inference. This insulates Blueprint from some software disruption risk. The natural constraint is time. Measuring health changes over a year requires waiting a year for results, which Johnson acknowledges limits how fast the inference engine can iterate.

Free tier

Johnson plans to build a free version that collects minimal viable data from users, feeds it into the inference engine, and generates actionable health guidance. His hypothesis is that once users experience the AI's accuracy—better prediction than they can achieve themselves—adoption becomes obvious. He invokes Facebook's early finding that 300 likes predicted users better than their partners could. The free version creates the world's largest health dataset. Users eventually get paid for their data as companies buy the insights. Johnson sees this as a financially incentivized ecosystem where he can credibly position Blueprint as always acting in users' best interest, unlike most companies.

Peptides and health skepticism

Johnson treats most health claims with skepticism. He dismisses organic labeling as mostly marketing. His testing shows organic products often perform worse than non-organic on many variables because organic certification only screens for a subset of toxins. He doesn't trust brands, practitioners, or marketing.

On peptides like semaglutide and tirzepatide, he acknowledges they're "fantastic" and drug-equivalent, but warns that many peptides circulating among longevity enthusiasts have no human clinical data. Unlike FDA-approved drugs, which come with characterized side effects, peptides lack that transparency. His position is to proceed with caution. He sees this as a blind spot in health culture where people chase positive signals without rigorously tracking downside risk.

Johnson credits the FDA with stopping literal snake oil and doing good work, but argues Blueprint and similar platforms will exceed FDA value in core areas because they can analyze real-world data on therapies like peptides that won't go through traditional clinical trials. If enough Immortals participants use peptides and contribute bio data, Blueprint could build a more valuable dataset than any single trial.

Olive oil

Johnson consumes three tablespoons (45 ml) of high-polyphenol olive oil daily—roughly 15% of his total caloric intake, one tablespoon with each meal. He sources from both hemispheres to ensure freshness, with this particular bottle from Chile under the Snake Oil brand. The oil stings slightly on ingestion, which he says signals quality. He positions olive oil as "the superfood of superfoods," citing broad benefits across health markers, but acknowledges the health industry hasn't pushed it more aggressively because of lingering fat-aversion bias from decades of "low-fat" marketing.

Philosophy

Johnson frames Blueprint as a bet that as AI advances and disrupts traditional work, humans will shift toward a "don't die" ideology. Rather than accept a post-work collapse narrative, he sees coming demand for biological vitality and longevity—an optimistic counterpoint to the black-pilled, short-term thinking he associates with some fitness trends. His framing: humans want to be alive and vibrant, and that desire will become "probably the most dominant ideology in the world very quickly."

Unresolved questions remain. Where to live if optimizing purely for health (he notes LA is poor for health). The role of wearables in capturing non-obvious signals like bedroom lighting. Whether a live human minder would be more effective than sensors. How to cycle supplements and fasting schedules for sustained benefit. On most, Johnson signals that his inference engine will provide answers as the dataset grows, but he's holding judgment until the data is robust.